- Home
- CALC vs NDLS Comparison
CALC vs NDLS Comparison
Compare CALC & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- NDLS
- Stock Information
- Founded
- CALC 2011
- NDLS 1995
- Country
- CALC United States
- NDLS United States
- Employees
- CALC N/A
- NDLS N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- CALC Health Care
- NDLS Consumer Discretionary
- Exchange
- CALC Nasdaq
- NDLS Nasdaq
- Market Cap
- CALC 48.1M
- NDLS 33.2M
- IPO Year
- CALC N/A
- NDLS 2013
- Fundamental
- Price
- CALC $2.85
- NDLS $0.67
- Analyst Decision
- CALC Strong Buy
- NDLS Buy
- Analyst Count
- CALC 2
- NDLS 2
- Target Price
- CALC $14.50
- NDLS $3.00
- AVG Volume (30 Days)
- CALC 63.4K
- NDLS 170.0K
- Earning Date
- CALC 11-12-2025
- NDLS 11-05-2025
- Dividend Yield
- CALC N/A
- NDLS N/A
- EPS Growth
- CALC N/A
- NDLS N/A
- EPS
- CALC N/A
- NDLS N/A
- Revenue
- CALC N/A
- NDLS $494,752,000.00
- Revenue This Year
- CALC N/A
- NDLS $1.19
- Revenue Next Year
- CALC N/A
- NDLS N/A
- P/E Ratio
- CALC N/A
- NDLS N/A
- Revenue Growth
- CALC N/A
- NDLS N/A
- 52 Week Low
- CALC $1.42
- NDLS $0.55
- 52 Week High
- CALC $5.65
- NDLS $1.74
- Technical
- Relative Strength Index (RSI)
- CALC 46.04
- NDLS 40.55
- Support Level
- CALC $3.00
- NDLS $0.66
- Resistance Level
- CALC $3.73
- NDLS $0.76
- Average True Range (ATR)
- CALC 0.35
- NDLS 0.03
- MACD
- CALC -0.00
- NDLS 0.00
- Stochastic Oscillator
- CALC 20.72
- NDLS 18.18
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.